This Article is no longer available, this page is showing similar articles.

Intellectual Property Law and Copyright Laws

Subscribe

Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.

Federal Court Of Appeal Confirms BYOOVIZ Is Confusing With Novartis' BEOVU Trademark

On November 28, 2025, the Federal Court of Appeal (FCA) upheld an injunction against the use of the trademark BYOOVIZ for an ophthalmic biosimilar, confirming the application judge's finding that the mark is likely...

SB

Smart & Biggar

CIPO Publishes IP Canada Report 2025

The Canadian Intellectual Property Office (CIPO) recently published its IP Canada Report 2025.

OW

Oyen Wiggs Green & Mutala LLP

Brand Protection: Essential Consideration For All Entrepreneurs

A brand can be a word mark, or an expression, and both might be used with design features; a brand can also be a logo or a slogan, all of which can form part of your brand.

FR

Fogler, Rubinoff LLP

Exclusive Right From Registered Trademark May Not Include Cross-Canada Recovery Of Damages

A trademark registration grants the owner the "exclusive right to the use throughout Canada of the trademark in respect of those goods or services" (Trademarks Act, section 19).

OW

Oyen Wiggs Green & Mutala LLP

Federal Court Of Appeal Clarifies Role Of Patients When Assessing Confusion For Pharmaceutical Trademarks

OW

Oyen Wiggs Green & Mutala LLP

Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes

MT

McCarthy Tétrault LLP

Government Financing Options For Intellectual Property

GW

Gowling WLG

Final Patented Medicines Pricing Guidelines From The PMPRB Take Effect On January 1, 2026: What This Means For Innovative Pharma

MT

McCarthy Tétrault LLP

Canadian Patent Law In Review 2025: Notable Decisions And Updates

C

Cassels

25 For 25: IP Milestones From The Last Quarter Century

LS

Lenczner Slaght LLP

Proposed Changes To The Plant Breeders' Rights Regulations

CC

CLC (Canadian Litigation Counsel)

Patent Infringement Damages Can Extend To Products Beyond Scope Of Claims

MT

McCarthy Tétrault LLP

Appeal Filed: Thaler Challenges Refusal To Recognize AI As An Inventor On A Patent—Implications Beyond Inventorship

BJ

Bennett Jones LLP

Federal Government Announces Intent To Create An Artist's Resale Right In Canada

OW

Oyen Wiggs Green & Mutala LLP

See more

Webinars

See More

20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 13 Nov 2025 | 3:00 PM

Unlocking IP Department Superpowers: From challenge to opportunity - Success Stories and Best Practices from IP Leaders

DG

Dennemeyer S.A.

Recorded on 21 Oct 2025 | 12:00 PM

From IPMS to Ecosystem: How APIs & Agentic AI transforms Intellectual Property work

DG

Dennemeyer S.A.

Recorded on 9 Jul 2025 | 2:00 PM

Digital Assets – Innovation vs Compliance: Emerging Offshore Jurisdictional Trends – How Legal Advisers' Roles Will Change

W

Walkers

Related Country Guides

Patent Litigation

Trademark Disputes

Licensing & Syndication

Understanding IP Infringement Risk In Typeface Use In AI-Generated Content

In the world of design, typefaces and fonts are essential tools that help convey a brand's identity, evoke emotions and communicate messages effectively.

BJ

Bennett Jones LLP

Licence To Film: Surveillance In Accident Benefits Claims (Video)

today my colleague Louise and I will be walking you through some of the key issues surrounding the use of surveillance at the LAT.

SB

SBA Lawyers LLP

Fragmented And Shifting CRISPR Patent Landscape: Global Proceedings And The Patent Pool Solution

Foundational CRISPR patent rights remain fiercely contested, with disputes playing out across multiple jurisdictions.

GW

Gowling WLG

No Cherry Picking Here: Canadian Cherry Patent Victory In U.S. Agribusiness Intellectual Property Case

F

Fasken

Licensing vs. Franchising: Understanding The Difference In Ontario

Pacific Legal PC

IP Licensing Primer Part Four: Payment And Quality Control

MA

MLT Aikins LLP

IP Licensing Primer Part Three: Term And Termination

MA

MLT Aikins LLP

IP Assets: A Guide To Maximizing Your Portfolio's Value

GW

Gowling WLG

Licensing Partnerships In Life Sciences: Emerging And Expected Trends In 2025

Canada Healthcare

GW

Gowling WLG

See more

Trade Secrets

X.AI Corp. v. OpenAI—Why Every Business (And Start-Up) Needs An Employee Governance Policy For Managing Confidential Business Information And IP Risk

A string of recent high-profile disputes, involving xAI suing both ChatGPT owner (OpenAI)1 and a former xAI engineer, shows how quickly job transitions can escalate into trade-secret crises for all parties involved.

BJ

Bennett Jones LLP

Can An AI System Be An Inventor?

There are now generative AI tools to assist with the development of software. These AI tools have been trained on large databases of open-source software.

Canada Technology

GW

Gowling WLG

Using IP To Remain Competitive When Developing Dual-use Technology

Dual-use technology refers to technologies that have both civilian and military applications.

SB

Smart & Biggar

Conserver son avantage concurrentiel dans le développement des technologies à double usage grâce à la propriété intellectuelle

SB

Smart & Biggar

Fallout From Trade Secret Theft In Taiwan

GL

Goodmans LLP

Designing The Future - Balancing Heritage And Innovation (Podcast)

GW

Gowling WLG

Why Canada Is On The USA IP Watch List?

BC

Brunet & Co

IP Basics: Trade Secrets (Podcast)

European Union IP

GW

Gowling WLG

Patents vs Trade Secrets In Canada – No, They're Not Just Alternatives

PL

Procido LLP

See more

Copyright

AI On The Horizon Event Series Part 4: AI & IP And AI Regulation (Video)

So my name is Roch Ripley. I am a partner in our IT Department here. My background before law school was electrical engineering.

Canada Technology

GW

Gowling WLG

25 For 25: IP Milestones From The Last Quarter Century

As 2025 draws to a close, we present a curated set of 25 turning points in Canadian intellectual property law from 2001–2025.

LS

Lenczner Slaght LLP

Federal Government Announces Intent To Create An Artist's Resale Right In Canada

Canadian artists should take note as an Artist's Resale Right may be on the horizon in Canada. In its 2025 Budget, the Canadian federal government announced its intention to create...

OW

Oyen Wiggs Green & Mutala LLP

Canadian Media vs. OpenAI: Ontario Court Gives A Procedural Greenlight

OW

Oyen Wiggs Green & Mutala LLP

In(dustry) Focus: Consumer Goods – A Complete IP Framework For Entering The Canadian Market

SB

Smart & Biggar

Pleins feux sur le secteur : une stratégie complète en matière de PI pour le lancement de biens de consommation sur le marché canadien

SB

Smart & Biggar

Moral Rights And Contractual Gaps: The Case Of A Hidden Mural

SB

Smart & Biggar

Les droits moraux et les lacunes contractuelles : le cas d'une murale cachée

SB

Smart & Biggar

AI Training On Trial: The Next Legal Frontier In Copyright Law

Canada Technology

OH

Osler, Hoskin & Harcourt LLP

See more

Patent

CIPO Publishes IP Canada Report 2025

The Canadian Intellectual Property Office (CIPO) recently published its IP Canada Report 2025.

OW

Oyen Wiggs Green & Mutala LLP

AI On The Horizon Event Series Part 4: AI & IP And AI Regulation (Video)

So my name is Roch Ripley. I am a partner in our IT Department here. My background before law school was electrical engineering.

Canada Technology

GW

Gowling WLG

Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes

À compter du 1er janvier 2026, le Conseil d'examen du prix des médicaments brevetés (CEPMB) mettra en œuvre de nouvelles Lignes directrices pour la surveillance des prix des médicaments brevetés au Canada.

MT

McCarthy Tétrault LLP

Government Financing Options For Intellectual Property

GW

Gowling WLG

Final Patented Medicines Pricing Guidelines From The PMPRB Take Effect On January 1, 2026: What This Means For Innovative Pharma

MT

McCarthy Tétrault LLP

Canadian Patent Law In Review 2025: Notable Decisions And Updates

C

Cassels

25 For 25: IP Milestones From The Last Quarter Century

LS

Lenczner Slaght LLP

Patent Infringement Damages Can Extend To Products Beyond Scope Of Claims

MT

McCarthy Tétrault LLP

DABUS Down, Not Done: Thaler Appeals Canadian Ruling On AI Inventorship

Worldwide Litigation

LS

Lenczner Slaght LLP

See more

Latest Videos

See more

Licence To Film: Surveillance In Accident Benefits Claims (Video)

SB

SBA Lawyers LLP

Is Your Song Ready For A TV Or Film Placement? — Pitfalls To Avoid (Video)

EC

Edwards Creative Law

The YouTube-ification Of Canadian Copyright Law (Video)

PL

Procido LLP

IP Explained: How To Use A Patent (Video)

FL

Field LLP

Law Talk Season 2 Episode 03: Business Law - Naming Your Business (Video)

FH

FH&P Lawyers

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More